Whitehawk Therapeutics (WHWK) EBT Margin (2018 - 2025)
Whitehawk Therapeutics (WHWK) reported EBT Margin of 1021.92% for Q1 2025, up 136356.0% year-over-year from N/an in Q1 2024, and up 504.84% on a QoQ basis from 252.42% in Q4 2024.
Whitehawk Therapeutics (WHWK) has 7 years of EBT Margin data on file, last reported at 1021.92% in Q1 2025.
- Quarterly EBT Margin rose 136356.0% year-over-year to 1021.92% in Q1 2025, while the trailing twelve-month figure through Dec 2025 was 1250.51% (up 149562.0% YoY) and the FY2025 annual result came in at 288.26%, down 4313.0% from the prior year.
- EBT Margin climbed to 1021.92% in Q1 2025 per WHWK's latest filing, from 252.42% in the prior quarter.
- Across five years, EBT Margin topped out at 1021.92% in Q1 2025 and bottomed at 4563.33% in Q1 2021.
- The 5-year median for EBT Margin is 266.35% (2022), against an average of 498.59%.
- The widest annual swing landed in 2021, when EBT Margin tumbled 17151 bps; it then jumped 396268 bps in 2022.
- Tracing WHWK's EBT Margin over 5 years: stood at 114.21% in 2021, then sank by 133 bps to 266.35% in 2022, then grew by 3 bps to 257.18% in 2023, then rose by 2 bps to 252.42% in 2024, then soared by 505 bps to 1021.92% in 2025.
- Per Business Quant, the three latest WHWK EBT Margin figures stand at 1021.92% (Q1 2025), 252.42% (Q4 2024), and 173.95% (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1,021.92% |
| Dec 31, 2024 | -252.42% |
| Sep 30, 2024 | -173.95% |
| Jun 30, 2024 | -235.98% |
| Mar 31, 2024 | -341.64% |
| Dec 31, 2023 | -257.18% |
| Sep 30, 2023 | -273.57% |
| Jun 30, 2023 | -289.76% |
| Mar 31, 2023 | -259.47% |
| Dec 31, 2022 | -266.35% |
| Sep 30, 2022 | -340.97% |
| Jun 30, 2022 | -531.28% |
| Mar 31, 2022 | -600.65% |
| Dec 31, 2021 | -114.21% |
| Mar 31, 2021 | -4,563.33% |
| Dec 31, 2020 | 57.29% |
| Sep 30, 2020 | -1,251.52% |
| Jun 30, 2020 | 61.84% |
| Dec 31, 2018 | -397,322.25% |
| Sep 30, 2018 | 61.26% |
| Jun 30, 2018 | -449.25% |